This message was sent to ##Email##
|
| April 27, 2016 |
| |  | | |
|
|
|
Medical Daily
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. In 1983, scientists first published evidence showing HPV causes cervical cancer in women, and now it is also known to cause cancers of the anus, mouth/throat, and penis in men. Hoping to limit the spread of this noxious virus, American health authorities began recommending HPV vaccination in 2007 for all girls and women between the ages of 9 and 26, and in 2011 they extended this recommendation to boys and men between the ages of 11 and 21.
READ MORE
ASCT
April 24-30, 2016
Medical Laboratory Professionals Week is an annual celebration of all laboratory personnel who play a critical role in every aspect of health care. Lab Week is the perfect time to honor the more than 300,000 medical laboratory professionals who work behind the scenes performing and interpreting more than 10 billion laboratory tests in the US per year. ASCT is proud to be one of 14 organizations that sponsor this important week in giving thanks to all laboratory professionals for their dedication to quality patient care.
| Date |
Event |
Location |
More information |
May 11, 2016
|
Error Reduction in the Cytopathology Laboratory |
Your PC |
 Kara Hansing, MEd, SCT(ASCP)
Cytotechnology Program Director
Mayo Clinic
Rochester, Minnesota
|
More info |
Register
|
June 15, 2016
|
Cell Blocks in Cytopathology: Methodology, Challenges and Solutions in Reference to IHC and Molecular Pathology |
Your PC |
 Kara Vinod B. Shidham, MD, FRCPath, FIAC
Vice-Chair – AP, Professor and
Director of Cytopathology;
Wayne State University SOM, DMC &
Karmanos Cancer Center;
Detroit, Michigan
|
More info |
Register
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
Yale University via Science Daily
A Yale-led study finds that a new vaccine for human papillomavirus would significantly reduce both cervical cancer incidence and healthcare costs if states coordinated policies to improve coverage.
The study was published April 18 by Proceedings of the National Academy of Sciences.
HPV, the most common sexually transmitted infection in the United States, is the primary cause of cervical cancer.
READ MORE
 |
|
The Cyto-Tek® 2500 offers excellent
preservation of cellular structure and consistently delivers a high rate of
cellular recovery. With its patented paced acceleration feature, the instrument
automatically increases and decreases the rotational velocity based on the selected
speed, which protects fragile cells and results in higher cellular yield.
|
|
DOTmed
Cervical cancer is the fourth most common cancer in women worldwide and early diagnosis is critical. A new study published in The Journal of Nuclear Medicine found that cervical cancer patients without enlarged lymph nodes may benefit from SPECT/MR imaging of their sentinel lymph nodes to determine if metastases are present.
Surgical removal and examination of the SLNs is currently the most accurate way to determine if the cancer has spread to the lymph nodes, but SPECT/MR imaging may help to reduce false negative MR findings in early-stage patients, and perhaps prevent some patients from having to undergo the invasive procedure.
READ MORE
HealthDay via Medical Xpress
Recommendations have been developed to increase human papillomavirus vaccine uptake, according to an American Society for Clinical Oncology special article published online April 11 in the Journal of Clinical Oncology.
READ MORE
Fusion
No one dreams of walking into his or her doctor’s office and hearing the words, “You have an STD,” followed by, “There is no cure.”
But for the many many people around the world who have been diagnosed with human papillomavirus, or HPV, this scenario is all too real. HPV is indeed incurable, and it strikes nearly every sexually active human at some point in his or her lifetime. Right now, according to the Centers for Disease Control and Prevention, 79 million Americans have the virus and doctors report roughly 14 million new cases every year in this country.
READ MORE
By Katina Smallwood
 By now, you've probably heard of Zika, the mosquito-borne virus infecting people across the Americas. You've also probably heard about the virus's suspected link to microcephaly, a birth defect causing infants to be born with abnormally small brains that can lead to developmental problems. But new reports have confirmed the link between Zika virus and microcephaly is indeed "causal," and Zika has also been linked to neurological disorders.
READ MORE
BBC News
A new type of cancer drug that wakes up the patient's own immune system to fight tumours could be a game changer for tackling aggressive head and neck cancers, say experts.
Trial results coming out of a US cancer conference suggest the treatment works better than standard chemotherapy.
Nivolumab significantly improved the survival odds of patients with these hard-to-treat tumours.
It is already available on the NHS for people with advanced skin cancer.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
